Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aarti, Chhatlani"'
Autor:
Hajra Ahmad, Kripa Balaram, Joel Dey, Ricardo Escobar, Thejasvi Lingamchetty, Rajesh R. Tampi, Aarti Chhatlani
Publikováno v:
The American Journal of Geriatric Psychiatry. 27:S161-S163
Introduction Substance use disorders are a growing problem among older adults that is largely unexplored and unaddressed. Acamprosate, disulfiram, and naltrexone are Food and Drug Administration (FDA) approved for the treatment of alcohol use disorde
Publikováno v:
The Journal of family practice. 68(1)
The USPSTF recommends the AUDIT, the AUDIT-C, or the single-question NIAAA screen. The CAGE screening tool has low sensitivity at lower levels of alcohol intake.
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 30(4)
Cariprazine was approved for treating schizophrenia and bipolar disorder, and currently is being evaluated for treating depression in clinical trials in the United States. We systematically reviewed the literature on the efficacy and safety of caripr
Autor:
Aarti, Chhatlani, Syeda Arshiya, Farheen, Geetha, Manikkara, Madhuri Jakkam, Setty, Elizabeth, DeOreo, Rajesh R, Tampi
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 30(4)
This systematic review evaluates current literature on anticonvulsants to treat alcohol withdrawal symptoms (AWS).We performed a literature search of PubMed, MEDLINE, PsycINFO, EMBASE, and Cochrane collaboration databases through September 30, 2016.